Journal article
ACE Inhibition in secondary prevention: are the results controversial?
Abstract
Results from the HOPE and EUROPA trials showed that ACE inhibitors lower cardiovascular mortality of patients with atherosclerosis and preserved left ventricular function. However, despite apparently adequate study design, the recently conducted PEACE trial detected no benefit of an additional ACE inhibitor treatment in patients with coronary artery disease and no heart failure with respect to cardiovascular risk reduction. One of the main …
Authors
Friedrich EB; Teo KK; Böhm M
Journal
Clinical Research in Cardiology, Vol. 95, No. 2, pp. 61–67
Publisher
Springer Nature
Publication Date
February 2006
DOI
10.1007/s00392-006-0334-6
ISSN
1861-0684